1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Shandong Weigao Group Medical Polymer Company Limited

Shandong Weigao Group Medical Polymer Company Limited

SHWGY
Shandong Weigao Group Medical Polymer Company LimitedUS flagOther OTC
1.74
USD
- -
- -
1.97BMarket Cap
Shandong Weigao Group Medical Polymer Company Limited
SHWGY
(Other OTC)

Recent

price

1.74

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
2.29
2.88
3.3
4.12
4.72
5.29
5.02
5.62
7.87
9.28
10.36
11.74
12.2
11.74
11.53
- -
Revenue per Share
0.74
3.13
0.89
0.35
0.97
0.99
0.99
1.54
1.32
1.65
1.86
2.02
2.45
1.78
1.82
- -
Basic EPS, GAAP
0.17
-0.64
-0.19
-0.26
-0.04
-0.07
0.37
-0.22
1.27
1.19
1.59
1.71
1.05
1.87
1.89
- -
Free Cash Flow per Basic Share
0.11
0.27
0.25
0.25
0.25
0.3
0.23
0.44
0.19
0.64
0.62
0.58
0.66
0.65
0.77
- -
Dividend per Share
0.2
0.41
5.54
5.64
6.36
7.05
7.74
0.4
0.4
0.4
0.4
0.41
15.78
16.93
17.9
- -
Book Value per Share
3.17
6.89
7.36
7.44
8.22
9.02
10.27
11.61
8.09
10.12
11.95
14.13
16.18
16.64
17.81
- -
Tangible Book Value per Share
1,076
1,104
1,119
1,119
1,119
1,119
1,119
1,119
1,119
1,119
1,122
1,125
1,126
1,127
1,135
- -
Basic Weighted Avg Shares
2,463
3,181
3,689
4,613
5,278
5,919
5,620
6,293
8,809
10,384
11,622
13,209
13,747
13,229
13,087
13,389
Sales/Revenue/Turnover
28.44
26.83
23.49
22.77
21.04
21.46
19.01
21.56
19.55
22.65
21.31
23.27
22.79
17.36
18.23
14.45
Operating Margin (%)
94
98
128
188
244
316
349
365
563
615
709
737
803
912
972
987
Depreciation Expense
799
3,462
996
388
1,085
1,113
1,106
1,729
1,473
1,850
2,087
2,276
2,764
2,002
2,067
1,612
Net Income, GAAP
9.63
3.46
11.53
28.76
14.18
13.98
12.96
14.71
14.56
14.52
13.97
14.6
12.87
12.98
15.31
15.79
Effective Tax Rate (%)
32.45
108.85
27.01
8.41
20.56
18.8
19.68
27.47
16.72
17.82
17.95
17.23
20.11
15.13
15.79
12.04
Profit Margin (%)
1,291
2,789
2,341
4,171
4,796
5,525
5,998
6,751
7,391
8,032
9,768
11,082
12,282
11,052
13,362
15,190
Working Capital
88
63
- -
100
149
649
792
804
5,093
4,454
4,015
3,513
3,501
1,596
2,951
4,605
LT Debt
3,634
8,212
8,920
9,063
9,880
10,787
12,205
13,638
15,191
16,992
18,879
21,047
23,582
23,993
25,342
25,820
Total Equity
18.24
13.67
8.91
8.13
9.65
9.9
7.38
8.25
8.36
9.33
9.32
10.84
10.17
7.06
7.02
5.38
Return on Invested Capital (%)
270.6
787
29.66
6.1
15.31
13.43
11.4
27.65
40.64
31.92
34.2
37.36
18.11
8.92
8.58
6.42
Return on Capital (%)
494.96
1,044.56
30
6.21
16.17
14.83
13.36
37.94
325.7
409.07
461.44
500.59
30.33
10.86
10.49
7.82
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.2%
6.56%
1.89%
Free Cash Flow
-141.09%
6.02%
-19.82%
Net Income, GAAP
6.35%
-3.16%
-21.99%
Sales/Revenue/Turnover
9.19%
3.04%
2.31%
Total Cash Common Dividend
28.28%
8.57%
18.57%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
13,229
2024
- -
- -
- -
- -
13,087
2025
- -
- -
- -
- -
13,389

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.78
2024
- -
- -
- -
- -
1.82
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.65
2024
- -
- -
- -
- -
0.77
2025
- -
- -
- -
- -
- -
Similar Companies
Safilo Group S.p.A. (SAFLF)
QuidelOrtho Corporation (QDEL)
Tevano Systems Holdings Inc. (TEVNF)
I.ceram S.A. (ALICR.PA)
Thai Optical Group Public Company Limited (TOG.BK)
Terumo Corporation (4543.T)
Business
Shandong Weigao Group Medical Polymer Company Limited Shandong Weigao Group Medical Polymer Company Limited (SHWGY) engages in the research, development, production, and sale of single-use medical devices, operating through segments including medical device products; orthopaedic products; interventional products; pharma packaging products; blood management products; and others. The company offers an extensive range of core products such as safe infusion sets, syringes, blood bags, blood component segregators, blood sampling products, prefilled syringes, medical needles including intravenous, syringe, catheter, and blood sampling variants; orthopaedic instruments and materials encompassing steel plates, screws, spinal implants, artificial joints, trauma products, sports medicine items, bone repair materials, and spinal endoscopes; interventional instruments for tumor and vascular procedures; pharmaceutical packaging solutions like pre-filled drug delivery systems, flushing syringes, and automatic drug delivery systems; blood management consumables for collection, irradiation, storage, separation, and sterilization; blood purification equipment including dialyzers, extracorporeal circuits, and puncture needles; as well as ancillary offerings such as medical PVC granules, plastic packing bags, finance leasing, and X-ray irradiation machines. Shandong Weigao Group Medical Polymer Company Limited, founded in 1988 and headquartered in Weihai, China, primarily serves healthcare organizations, hospitals, blood stations, and medical units in China and exports to over 100 countries and regions, positioning it as a specialized overall solution provider in the medical device industry with involvement in more than 100 industry standards. Recent developments include Shandong Weigao Blood Purification Products Co., a subsidiary, pursuing the acquisition of Shandong Wego Prefills Pharmaceutical Packaging Co in October 2025 to strengthen pharma packaging capabilities; new product registrations such as the non-phthalic light-avoiding automatic stop infusion device and single-use sterile needles in August 2024; and a technological breakthrough in ultra-thin wall, high-throughput, high-strength medical beauty needles in June 2024, alongside a cooperation framework agreement with the Shandong Medical Association in August 2024.